New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
10:24 EDTYUM, PLD, JBLU, HOG, HES, XOM, UNP, OPEN, ITW, GGG, PCH, CP, USB, LEN, HA, FOSL, IDIX, AMZN, FOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Amazon.com (AMZN) downgraded to Outperform from Buy at CLSA... Ford (F) downgraded to Underperform from Outperform at CLSA... Fossil (FOSL) downgraded to Sell from Hold at Brean Capital... Graco (GGG) downgraded to Neutral from Buy at Janney Capital... Harley-Davidson (HOG) downgraded to Neutral from Buy at Goldman... Hawaiian Holdings (HA) downgraded to Hold from Buy at Deutsche Bank... Illinois Tool Works (ITW) downgraded to Market Perform from Outperform at BMO Capital... JetBlue (JBLU) downgraded to Underperform from Market Perform at Raymond James... Lennar (LEN) downgraded to Neutral from Outperform at Credit Suisse... OpenTable (OPEN) downgraded to Perform from Outperform at Oppenheimer... ProLogis (PLD) downgraded to Market Perform from Outperform at Wells Fargo... U.S. Bancorp (USB) downgraded to Neutral from Overweight at JPMorganbas... Union Pacific (UNP) downgraded to Neutral from Overweight at Atlantic Equities... Yum! Brands (YUM) downgraded to Market Perform from Outperform at Bernstein... Canadian Pacific (CP) downgraded to Hold from Buy at Stifel Nicolaus... Exxon Mobil (XOM) downgraded to Neutral from Outperform at Macquarie... Idenix (IDIX) downgraded to Neutral from Outperform at Wedbush... Potlatch (PCH) downgraded to Underperform from Neutral at DA Davidson... Hess Corp. (HES) downgraded to Neutral from Add at Capital One.
News For AMZN;F;GGG;HOG;HA;ITW;JBLU;LEN;OPEN;PLD;USB;UNP;YUM;CP;XOM;IDIX;PCH;HES;FOSL From The Last 14 Days
Check below for free stories on AMZN;F;GGG;HOG;HA;ITW;JBLU;LEN;OPEN;PLD;USB;UNP;YUM;CP;XOM;IDIX;PCH;HES;FOSL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
April 7, 2014
12:47 EDTFFord recalls 434,000 vehicles in two unrelated recalls, Detroit News reports
Ford is recalling more than 434,000 vehicles in two separate recalls announced Monday, reports Detroit News. The company is recalling 385,750 Escape compact SUVs due to a rusty subframe. it also will recall 48,950 Ford Fusion, Lincoln MKZ, Ford Escape and C-Max vehicles to replace seatback frames that don't comply to the NHTSA standard. Reference Link
12:10 EDTAMZNAmazon.com tests Friday's session lows, levels to watch
Subscribe for More Information
10:32 EDTJBLUAirline stocks rally after Goldman ups sector rating
Airline stocks are rising in a down market after Goldman Sachs raised its rating on the sector to Attractive from Neutral. WHAT'S NEW: Although airline stocks have already outperformed the market, it's not too late for investors to get involved in the sector, Goldman wrote in a note to investors earlier today. Not yet priced into the stock are higher ticket prices, more crowded planes, and a recovering U.S. consumer, according to the firm. It initiated coverage of American Airlines (AAL) with a Buy rating and upgraded its rating on JetBlue (JBLU) to Neutral from Sell. Goldman kept Buy ratings on Delta (DAL) and United Continental (UAL). PRICE ACTION: In mid-morning trading, American Airlines rose 1.25% to $37, JetBlue added 0.6% to $8.80, Delta gained 2% to $35.30, and United Continental lost 0.5% to $44.65.
10:00 EDTJBLUOn The Fly: Analyst Upgrade Summary
Agios Pharmaceuticals (AGIO) upgraded to Overweight from Neutral at JPMorgan... Alcoa (AA) upgraded to Hold from Sell at Deutsche Bank... Align Technology (ALGN) upgraded to Outperform from Market Perform at Barrington... Analog Devices (ADI) upgraded to Neutral from Sell at Goldman... B&G Foods (BGS) upgraded to Outperform from Sector Perform at RBC Capital... Citigroup (C) upgraded to Neutral from Underweight at HSBC... Intel (INTC) upgraded to Outperform from Sector Perform at Pacific Crest... JetBlue (JBLU) upgraded to Neutral from Sell at Goldman... Kindred Healthcare (KND) upgraded to Outperform from Sector Perform at RBC Capital... Lennox (LII) upgraded to Outperform from Market Perform at Wells Fargo... Newmont Mining (NEM) upgraded to Hold from Sell at Deutsche Bank... PBF Energy (PBF) upgraded to Buy from Neutral at Citigroup... Renasant (RNST) upgraded to Outperform from Market Perform at Raymond James... Select Medical (SEM) upgraded to Outperform from Sector Perform at RBC Capital... Ultra Petroleum (UPL) upgraded to Outperform from Market Perform at Raymond James... Under Armour (UA) upgraded to Buy from Neutral at Sterne Agee... Hercules Technology (HTGC) upgraded to Buy from Hold at Sandler ONeill... Standard Pacific (SPF) upgraded to Outperform from Market Perform at Raymond James... Yelp (YELP) upgraded to Outperform from Perform at Oppenheimer... Netflix (NFLX) upgraded to Outperform from Perform at Oppenheimer... Pandora (P) upgraded to Outperform from Neutral at Wedbush.
09:34 EDTAMZNActive equity options trading on open
Subscribe for More Information
07:35 EDTAMZNAmazon.com announces launch of Amazon Dash
Subscribe for More Information
07:15 EDTIDIXIdenix announces promising clinical data, continued progress in HCV programs
Idenix Pharmaceuticals announced continued progress of the Company's program to develop nucleotide prodrug inhibitors for the treatment of hepatitis C virus, or HCV, infection. Idenix is reporting potent antiviral activity of mean maximum 4.2-4.3 log10 IU/mL reductions for patients infected with HCV genotype 1, 2 or 3 receiving 300 mg once daily of IDX21437 in the seven-day proof-of-concept portion of a phase I/II clinical trial. Based on this progress, the Company's goal is to initiate a combination clinical trial of IDX21437 and samatasvir, a pan-genotypic NS5A inhibitor, in mid-2014. In addition, Idenix has selected a follow-on uridine-based nucleotide prodrug, IDX21459, from its ongoing nucleotide discovery program and initiated enrollment for the healthy volunteer portion of a phase I clinical trial. In January, Idenix initiated the seven-day proof-of-concept portion of a phase I/II clinical trial for IDX21437. The trial completed enrollment of 44 treatment-nave, genotype, or GT, 1, 2 or 3 HCV-infected patients. Patients were randomized to receive once-daily doses of placebo, 50 mg, 150 mg, or 300 mg of IDX21437 for seven days. In April 2014, Idenix initiated enrollment for the healthy volunteer portion of a phase I clinical trial of IDX21459 in Europe. This portion of the study is expected to enroll approximately 50 healthy volunteers and will evaluate once-daily doses of IDX21459 ranging from 10 mg 300 mg. The proof-of-concept portion of the study is expected to enroll a total of 40 treatment-nave, genotype 1 HCV-infected patients who will receive once-daily doses of placebo, 50 - 300 mg of IDX21459 for seven days. IDX21459 has shown a favorable preclinical profile including potent, pan-genotypic activity and favorable safety with respect to cardiac, mitochondrial and genotoxicity assessments.
07:09 EDTJBLUAirline quality study shows customer complaint improvement, Reuters says
Subscribe for More Information
06:41 EDTAMZNMicrosoft pushes for programming to rival Amazon, Netflix, Bloomberg says
Subscribe for More Information
06:14 EDTJBLUAirlines sector upgraded to Attractive from Neutral at Goldman
Goldman upgraded the Airlines sector to Attractive from Neutral based on a more bullish views on the cycle and improving demand. The analyst believes consensus estimates underestimate pricing, which will boost multiples. As part of the sector change, the firm initiated American Airlines (AAL) with a Buy rating and upgraded JetBlue (JBLU) to Neutral from Sell.
06:10 EDTJBLUJetBlue upgraded to Neutral from Sell at Goldman
Goldman upgraded JetBlue citing improving domestic pricing prospects. Price target is$10.50.
05:25 EDTFFord Transit Connect awarded five star safety rating by NHTSA
Subscribe for More Information
April 6, 2014
17:48 EDTAMZNGoogle set to announce Android TV, The Verge says
Subscribe for More Information
14:21 EDTAMZNYahoo plans to acquire bigger budget TV programming, WSJ says
Subscribe for More Information
April 4, 2014
17:12 EDTAMZNMarket finishes mixed as Nasdaq sells off into weekend
Subscribe for More Information
16:30 EDTAMZNOn The Fly: Closing Wrap
Subscribe for More Information
10:53 EDTITW High option volume stocks: ITW CTRX WMC LQD IMGN
Subscribe for More Information
09:47 EDTAMZNAmazon.com downside continues, levels to watch
Subscribe for More Information
09:36 EDTAMZNActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TSLA MU GNK AMZN FB GILD MA NFLX
07:55 EDTFFord outpacing rivals in China on strength of SUVs, WSJ says
Thanks in large part to a rising demand in China for sport-utility vehicles, Ford's (F) China deliveries jumped past Toyota (TM) in 2013 and the U.S. automaker also gained on General Motors (GM) and Volkswagen (VLKAY), who it has similarly trailed in China for years, reported The Wall Street Journal. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use